These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1754634)

  • 21. Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6.
    Young D; Midha KK; Fossler MJ; Hawes EM; Hubbard JW; McKay G; Korchinski ED
    Eur J Clin Pharmacol; 1993; 44(5):433-8. PubMed ID: 8359179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower plasma levels of haloperidol in smoking than in nonsmoking schizophrenic patients.
    Shimoda K; Someya T; Morita S; Hirokane G; Noguchi T; Yokono A; Shibasaki M; Takahashi S
    Ther Drug Monit; 1999 Jun; 21(3):293-6. PubMed ID: 10365639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced haloperidol and haloperidol: effects on homovanillic acid in caudate and prefrontal cortex.
    Chang WH; Wu HS; Tseng YT
    Biol Psychiatry; 1987 Nov; 22(11):1369-74. PubMed ID: 3663789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haloperidol reductase activity in red blood cells from oriental patients on haloperidol.
    Someya T; Shibasaki M; Kato T; Noguchi T; Ishida N; Takahashi S
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):275-8. PubMed ID: 1871328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interindividual variation of serum haloperidol concentrations in Japanese patients--clinical considerations on steady-state serum level-dose ratios.
    Yukawa E; Ichimaru R; Maki T; Matsunaga K; Anai M; Yukawa M; Higuchi S; Goto Y
    J Clin Pharm Ther; 2003 Apr; 28(2):97-101. PubMed ID: 12713605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting the clinical response to haloperidol therapy in schizophrenia.
    Bareggi SR; Mauri M; Cavallaro R; Regazzetti MG; Moro AR
    Clin Neuropharmacol; 1990; 13 Suppl 1():S29-34. PubMed ID: 2379182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haloperidol plasma concentrations in Taiwanese psychiatric patients.
    Lane HY; Lin HN; Hwu HG; Jann M; Hu WH; Chang WH
    J Formos Med Assoc; 1995 Nov; 94(11):671-8. PubMed ID: 8527974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol.
    Pan L; Belpaire FM
    Eur J Clin Pharmacol; 1999 Oct; 55(8):599-604. PubMed ID: 10541779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: the analysis of therapeutic drug monitoring data.
    Hirokane G; Someya T; Takahashi S; Morita S; Shimoda K
    Ther Drug Monit; 1999 Feb; 21(1):82-6. PubMed ID: 10051058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent reduced haloperidol/haloperidol ratios: influence of patient-related variables.
    Lane HY; Chang WH; Chang YC; Hu OY; Lin HN; Jann MW; Hu WH
    Psychiatry Res; 1997 Sep; 72(2):127-32. PubMed ID: 9335203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of haloperidol reductase activity in red blood cells and reduced haloperidol/haloperidol ratios in plasma in oriental psychiatric patients.
    Shibasaki M; Someya T; Kato T; Noguchi T; Ishida N; Takahashi S
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):941-7. PubMed ID: 2277853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.
    Piscitelli SC; Frazier JA; McKenna K; Albus KE; Grothe DR; Gordon CT; Rapoport JL
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():94-7. PubMed ID: 7961584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of smoking and cytochrome P450 2D6*10 allele on the plasma haloperidol concentration/dose ratio.
    Ohara K; Tanabu S; Yoshida K; Ishibashi K; Ikemoto K; Shibuya H
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):945-9. PubMed ID: 14499311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2D6*10 alleles are not the determinant of the plasma haloperidol concentrations in Asian patients.
    Shimoda K; Morita S; Yokono A; Someya T; Hirokane G; Sunahara N; Takahashi S
    Ther Drug Monit; 2000 Aug; 22(4):392-6. PubMed ID: 10942177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of age and the CYP2D6*10 allele on the plasma haloperidol concentration/dose ratio.
    Ohara K; Tanabu S; Ishibashi K; Ikemoto K; Yoshida K; Shibuya H
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):347-50. PubMed ID: 12691769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interindividual variation in bromperidol metabolism and relationship to therapeutic effects.
    Someya T; Muratake T; Hirokane G; Shibasaki M; Shimoda K; Takahashi S
    J Clin Psychopharmacol; 2000 Apr; 20(2):175-80. PubMed ID: 10770455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia.
    Kelly MW; Perry PJ; Coryell WH; Miller DD; Arndt SV
    Psychopharmacology (Berl); 1990; 102(4):514-20. PubMed ID: 2096408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma concentrations of timiperone and its reduced metabolite in the patients on timiperone.
    Shimoda K; Someya T; Morita S; Hirokane G; Yokono A; Shibasaki M; Takahashi S
    Psychiatry Clin Neurosci; 1998 Oct; 52(5):535-40. PubMed ID: 10215017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients.
    Roh HK; Chung JY; Oh DY; Park CS; Svensson JO; Dahl ML; Bertilsson L
    Br J Clin Pharmacol; 2001 Sep; 52(3):265-71. PubMed ID: 11560558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steady-state pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients: analysis of factors determining their concentrations in hair.
    Uematsu T; Matsuno H; Sato H; Hirayama H; Hasegawa K; Nakashima M
    J Pharm Sci; 1992 Oct; 81(10):1008-11. PubMed ID: 1432610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.